Alnylam Pharmaceuticals reported $598.93M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 161.58M 6.63M
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Amgen AMGN:US USD 3.91B 504M
Arrowhead Research ARWR:US USD 105.32M 4.93M
Avrobio Inc AVRO:US USD 22.98M 4.79M
Biocryst Pharmaceuticals BCRX:US USD 93.27M 6.98M
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
IONIS PHARMACEUT IONS:US USD 218.92M 384K
Mirati Therapeutics MRTX:US USD 191.87M 9.31M
Moderna Inc MRNA:US USD 2.2B 104M
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Novartis NVS:US USD 10.67B 183M
Ptc Therapeutics PTCT:US USD 285.31M 27.43M
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Regulus Therapeutics RGLS:US USD 7.56M 388K
Sangamo Biosciences SGMO:US USD 81.35M 6.24M
Sarepta Therapeutics SRPT:US USD 487.06M 42.45M
Takeda 4502:JP JPY 897.87B 75.92B
Ultragenyx Pharmaceutical RARE:US USD 315.77M 84.83M
Vertex Pharmaceuticals VRTX:US USD 1.21B 117.7M
Xencor XNCR:US USD 65.65M 7.47M
YTE INCY:US USD 684.93M 27.96M